Myths And Facts

There’s a lot of misinformation out there. Get the facts.

Myth

Fact

Myth

340B was intended to deliver discounted drugs directly to patients.

Fact

340B was created to allow safety-net providers to buy outpatient medicines for less. They use the savings to stretch resources so they can provide a variety of services, drugs, and better care to patients who can’t always pay.

Myth

340B uses taxpayer money.

Fact

340B is not funded by taxpayers. Instead, drug companies sell drugs to providers at discounted prices, allowing them to stretch their existing funding even further. A government agency, the Office of Pharmacy Affairs, receives a small congressional appropriation to administer the program.

Myth

Too many providers qualify for 340B.

Fact

Both Republicans and Democrats have expanded 340B to cover those parts of the safety net people need most. For example, the most recent expansion added small rural hospitals with 25 or fewer beds that guarantee access to care in some of the most remote parts of our country.

Myth

340B is a big drain on drug companies.

Fact

The 340B program represents just 2 percent of the $374 billion U.S. drug market.  Drugs sold abroad often cost less than drugs discounted under 340B.

Myth

Hospitals already have enough money.

Fact

For-profit hospitals are ineligible for 340B. Only public and nonprofit hospitals that serve large numbers of Medicaid and low-income Medicare patients or are located in rural areas qualify. Many of these providers operate at a loss.

Myth

340B hospitals provide less charity care than average.

Fact

While charity care is not an eligibility requirement for the program, 340B hospitals provide 60 percent of all uncompensated care. DSH hospitals participating in 340B provide more than twice as much care to Medicaid and low-income Medicare patients as non-340B hospitals.

Myth

The Affordable Care Act made 340B unnecessary.

Fact

Twenty-seven million Americans will remain uninsured over the next 10 years, according to the Congressional Budget Office. Millions more will be underinsured and unable to pay for all their medicines and care.  The need for the 340B program is stronger than ever.

News

A program that works exactly as intended The Hill
340B Hospitals Treat More Low-Income Cancer Patients Than Non-340B Providers 340B Informed
Commentary: Predatory drug pricing harms patients, health care reform Austin American-Statesman
City Hospitals Worry Discount Drug Overhaul May Go Too Far in Limiting Access New York One
Drug discount pricing program that’s crucial to JPS is at risk Fort Worth Star-Telegram
Congress should not cut drug program Wichita Eagle
Viewpoint: A shield South Bend Tribune
Drug discount program saves lives The Baltimore Sun
Fact Check on Drug Discount Program Town Hall
Rural Hospitals at Risk Morning Consult
We Must Protect Vital ‘340B’ Drug Discounts for Safety Net Hospitals Huffington Post
Addressing High Drug Prices The Washington Times
Letters: I am living proof that the 340B Drug Pricing Program saves lives The Advocate
Drug discount program saves lives Greensburg Daily News
Congressional Republicans Need to Play Smart During This Election Season The Blaze
My view: Rural hospitals depend on 340B drug pricing program Deseret News
Comment | Drug-pricing program vital to rural Ky. The Courier-Journal
Armstrong: Time to make the right call on health care for Texas The Houston Chronicle
Letter: Don’t Eliminate 340B Drug-Pricing Program Springfield News-Leader
Congress needs to tackle the real driver of healthcare costs The Hill
The 340B Program’s Vital Role in Oncology Care Oncology Payers
Program offers prescription savings News Press Now
Safety-net hospitals indeed treat the underserved The Hill
Don’t cut program that cuts cost of prescription drugs The Hill
Preserve program to help the poor get low-cost medicine St. Louis Post-Dispatch
Want to Protect Women’s Rights? Preserve 340B Morning Consult
Letter: Hospitals not getting rich off 340B discounts AJC
A drug discount program that punches above its weight The Hill
Drug Discount Program Vital to Cancer Patients Queens Ledger
Don’t let pharmaceutical companies gouge the poor The Express-Times
340B drug pricing plan vital to low-income health Delaware County Daily Times
Congress should tell Big Pharma to pick on someone their own size Tulsa World
Oklahoma’s rural hospitals need every lifeline The Oklahoman
Don’t gut important drug discount program Pal-Item
Vital drug discount is under siege in Congress The Daily Progress
Big pharma seeks more profits on the backs of the poor The Eagle
Lifesaving 340B discount drug program under attack Cleveland Plain Dealer
Congress must protect program critical for rural hospitals Southern Illinoisan
Without price breaks, rural hospitals struggle to stock costly, lifesaving drugs Kaiser Health News
Hospitals need 340B more than ever Grand Forks Herald
About the 340B program Pierce County Tribune
Keep prescriptions affordable Daily Journal
340B is vital for Iowa’s critical access hospitals Des Moines Register
Hill lawmakers race to block HHS Medicare cuts to 340B hospitals Modern Healthcare
340B: A Key Part of Ending the HIV/AIDS Epidemic 340B Informed
Heated and Deep-Pocketed Battle Erupts Over 340B Drug Discount Program Kaiser Health News

Videos

340B Drug Discount Program Explained